Eileen Graffunder

1.9k total citations
16 papers, 1.5k citations indexed

About

Eileen Graffunder is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Eileen Graffunder has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Clinical Biochemistry. Recurrent topics in Eileen Graffunder's work include Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Pneumonia and Respiratory Infections (4 papers). Eileen Graffunder is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Pneumonia and Respiratory Infections (4 papers). Eileen Graffunder collaborates with scholars based in United States and Singapore. Eileen Graffunder's co-authors include Thomas P. Lodise, Jeffrey Graves, Ben M. Lomaestro, A. Evans, Kathleen A. Stellrecht, Richard A. Venezia, Jessina C. McGregor, Jon P. Furuno, Nimish Patel and Andrea Lay‐Hoon Kwa and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Transplantation and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Eileen Graffunder

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen Graffunder United States 11 772 649 385 353 268 16 1.5k
J. A. Martínez Spain 18 794 1.0× 670 1.0× 768 2.0× 231 0.7× 168 0.6× 30 2.1k
Young Eun Ha South Korea 24 881 1.1× 343 0.5× 636 1.7× 460 1.3× 144 0.5× 88 1.9k
Jeffrey Graves United States 8 860 1.1× 685 1.1× 363 0.9× 239 0.7× 467 1.7× 9 1.3k
B. Byl Belgium 24 573 0.7× 349 0.5× 771 2.0× 302 0.9× 169 0.6× 50 1.9k
Murray A. Abramson United States 17 459 0.6× 295 0.5× 384 1.0× 344 1.0× 218 0.8× 27 1.9k
E.-C. Kim South Korea 13 554 0.7× 377 0.6× 678 1.8× 370 1.0× 136 0.5× 17 1.3k
Jennifer S. McDanel United States 13 667 0.9× 337 0.5× 357 0.9× 187 0.5× 175 0.7× 25 1.1k
Paul B. Iannini United States 22 424 0.5× 514 0.8× 625 1.6× 288 0.8× 333 1.2× 43 1.6k
Pam Tolomeo United States 21 420 0.5× 313 0.5× 614 1.6× 522 1.5× 227 0.8× 90 1.4k
Matthaios Papadimitriou‐Olivgeris Switzerland 19 552 0.7× 294 0.5× 490 1.3× 530 1.5× 205 0.8× 98 1.3k

Countries citing papers authored by Eileen Graffunder

Since Specialization
Citations

This map shows the geographic impact of Eileen Graffunder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Graffunder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Graffunder more than expected).

Fields of papers citing papers by Eileen Graffunder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Graffunder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Graffunder. The network helps show where Eileen Graffunder may publish in the future.

Co-authorship network of co-authors of Eileen Graffunder

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Graffunder. A scholar is included among the top collaborators of Eileen Graffunder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Graffunder. Eileen Graffunder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Johnson, J. Kristie, et al.. (2017). Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia. The Journal of Pediatric Pharmacology and Therapeutics. 22(3). 218–226. 10 indexed citations
2.
Cummings, James J., et al.. (2015). Prevention of postnatal growth restriction by the implementation of an evidence-based premature infant feeding bundle. Journal of Perinatology. 35(8). 642–649. 15 indexed citations
3.
Graffunder, Eileen, et al.. (2015). Use of a Feeding Bundle Appears to Reduce Central Line Utilization in Neonates. Journal of Pediatric Gastroenterology and Nutrition. 61(2). 260–264. 2 indexed citations
4.
Lodise, Thomas P., George L. Drusano, Victoria Lazariu, et al.. (2014). Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin . Journal of Antimicrobial Chemotherapy. 69(9). 2547–2555. 3 indexed citations
5.
Patel, Nimish, Susan M. Harrington, Benjamin K.P. Woo, et al.. (2011). Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. Journal of Antimicrobial Chemotherapy. 66(7). 1600–1608. 56 indexed citations
6.
Lodise, Thomas P., Jeffrey Graves, A. Evans, et al.. (2008). Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin. Antimicrobial Agents and Chemotherapy. 52(9). 3315–3320. 457 indexed citations
7.
Lodise, Thomas P., Chris D. Miller, Jeffrey Graves, et al.. (2008). Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy. 62(5). 1138–1141. 60 indexed citations
8.
Lodise, Thomas P., Nimish Patel, Andrea Lay‐Hoon Kwa, et al.. (2007). Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic Selection. Antimicrobial Agents and Chemotherapy. 51(10). 3510–3515. 251 indexed citations
9.
Lodise, Thomas P., Christopher Miller, Jeffrey Graves, et al.. (2006). Clinical Prediction Tool To Identify Patients with Pseudomonas aeruginosa Respiratory Tract Infections at Greatest Risk for Multidrug Resistance. Antimicrobial Agents and Chemotherapy. 51(2). 417–422. 43 indexed citations
10.
Graffunder, Eileen, Karen E. Preston, A. Evans, & Richard A. Venezia. (2005). Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital. Journal of Antimicrobial Chemotherapy. 56(1). 139–145. 66 indexed citations
11.
Preston, Karen E., Eileen Graffunder, A. Evans, & Richard A. Venezia. (2003). Survey of Plasmid-Associated Genetic Markers in Enterobacteriaceae with Reduced Susceptibilities to Cephalosporins. Antimicrobial Agents and Chemotherapy. 47(7). 2179–2185. 18 indexed citations
12.
Graffunder, Eileen. (2002). Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. Journal of Antimicrobial Chemotherapy. 49(6). 999–1005. 323 indexed citations
13.
Bowes, Jennifer, Eileen Graffunder, Ben M. Lomaestro, & Richard A. Venezia. (2002). Concomitant Administration of Drugs Known to Decrease the Systemic Availability of Gatifloxacin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(6). 800–801. 1 indexed citations
14.
Graffunder, Eileen, et al.. (2001). Risk Factors for Surgical-Site Infections Following Cesarean Section. Infection Control and Hospital Epidemiology. 22(10). 613–617. 129 indexed citations
15.
Hahn, Amy B., Jane Kasten‐Jolly, Eileen Graffunder, et al.. (2001). TNF-??, IL-6, IFN-??, AND IL-10 GENE EXPRESSION POLYMORPHISMS AND THE IL-4 RECEPTOR ??-CHAIN VARIANT Q576R: EFFECTS ON RENAL ALLOGRAFT OUTCOME. Transplantation. 72(4). 660–665. 69 indexed citations
16.
Hahn, Amy B., et al.. (2001). PROMOTER-REGION ALLELES OF THE TNF-?? AND IL-10 GENES HAVE NO EFFECT ON PRETRANSPLANT ALLOANTIBODY PRODUCTION1. Transplantation. 72(4). 739–742. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. A. Martínez Breakdown of academic impact, for papers by Young Eun Ha Breakdown of academic impact, for papers by Jeffrey Graves Breakdown of academic impact, for papers by B. Byl Breakdown of academic impact, for papers by Murray A. Abramson Breakdown of academic impact, for papers by E.-C. Kim Breakdown of academic impact, for papers by Jennifer S. McDanel Breakdown of academic impact, for papers by Paul B. Iannini Breakdown of academic impact, for papers by Pam Tolomeo Breakdown of academic impact, for papers by Matthaios Papadimitriou‐Olivgeris
Rankless by CCL
2026